Inclusion of omalizumab in a trastuzumab desensitization protocol

Farm Hosp. 2022 Mar 26;46(3):199-201.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Desensitization, Immunologic / methods
  • Drug Hypersensitivity* / etiology
  • Drug Hypersensitivity* / therapy
  • Humans
  • Omalizumab* / therapeutic use
  • Trastuzumab / adverse effects

Substances

  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • Trastuzumab